HL 34545/HL/NHLBI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1986	1
1987	1
1988	2
1989	2
1991	4
1992	1
1995	1
2022	0

1

Altered lipid profile after Kawasaki syndrome.

Newburger JW, Burns JC, Beiser AS, Loscalzo J. Newburger JW, et al. Circulation. 1991 Aug;84(2):625-31. doi: 10.1161/01.cir.84.2.625. Circulation. 1991. PMID: 1860206

2

Incomplete Kawasaki disease with coronary artery involvement.

Rowley AH, Gonzalez-Crussi F, Gidding SS, Duffy CE, Shulman ST. Rowley AH, et al. J Pediatr. 1987 Mar;110(3):409-13. doi: 10.1016/s0022-3476(87)80503-6. J Pediatr. 1987. PMID: 3819942

3

The treatment of Kawasaki syndrome with intravenous gamma globulin.

Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP, et al. Newburger JW, et al. N Engl J Med. 1986 Aug 7;315(6):341-7. doi: 10.1056/NEJM198608073150601. N Engl J Med. 1986. PMID: 2426590 Clinical Trial.

4

Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group.

Burns JC, Mason WH, Glode MP, Shulman ST, Melish ME, Meissner C, Bastian J, Beiser AS, Meyerson HM, Newburger JW. Burns JC, et al. J Pediatr. 1991 May;118(5):680-6. doi: 10.1016/s0022-3476(05)80026-5. J Pediatr. 1991. PMID: 2019921 Clinical Trial.

5

Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin.

Newburger JW, Sanders SP, Burns JC, Parness IA, Beiser AS, Colan SD. Newburger JW, et al. Circulation. 1989 Jun;79(6):1237-46. doi: 10.1161/01.cir.79.6.1237. Circulation. 1989. PMID: 2720925 Clinical Trial.

6

Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood.

Finberg RW, Newburger JW, Mikati MA, Heller AH, Burns JC. Finberg RW, et al. J Pediatr. 1992 Mar;120(3):376-80. doi: 10.1016/s0022-3476(05)80900-x. J Pediatr. 1992. PMID: 1538283

7

Lack of effect of gamma-globulin infusion on circulating immune complexes in patients with Kawasaki syndrome.

Mason W, Jordan S, Sakai R, Takahashi M. Mason W, et al. Pediatr Infect Dis J. 1988 Feb;7(2):94-9. doi: 10.1097/00006454-198802000-00006. Pediatr Infect Dis J. 1988. PMID: 2449651 Clinical Trial.

8

A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.

Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, et al. Newburger JW, et al. N Engl J Med. 1991 Jun 6;324(23):1633-9. doi: 10.1056/NEJM199106063242305. N Engl J Med. 1991. PMID: 1709446 Free article. Clinical Trial.

9

Conjunctival biopsy in patients with Kawasaki disease.

Burns JC, Wright JD, Newburger JW, Schneeberger EE, Mierau GW, Smith LE. Burns JC, et al. Pediatr Pathol Lab Med. 1995 Jul-Aug;15(4):547-53. doi: 10.3109/15513819509026990. Pediatr Pathol Lab Med. 1995. PMID: 8597841

10

Decreased protein binding of salicylates in Kawasaki disease.

Koren G, Silverman E, Sundel R, Edney P, Newburger JW, Klein J, Robieux I, Laxer R, Giesbrecht E, Burns JC. Koren G, et al. J Pediatr. 1991 Mar;118(3):456-9. doi: 10.1016/s0022-3476(05)82168-7. J Pediatr. 1991. PMID: 1999792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results